TCIM
UTMD icon

TIAA CREF Investment Management’s Utah Medical Products UTMD Stock Holding History

TIAA CREF Investment Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$612K Sell
6,936
-92
-1% -$8.09K ﹤0.01% 2521
2018
Q4 		$584K Hold
7,028
– – ﹤0.01% 2505
2018
Q3 		$662K Sell
7,028
-290
-4% -$27.7K ﹤0.01% 2609
2018
Q2 		$806K Sell
7,318
-893
-11% -$93.3K ﹤0.01% 2583
2018
Q1 		$812K Sell
8,211
-2,810
-25% -$251K ﹤0.01% 2533
2017
Q4 		$897K Buy
11,021
+1,762
+19% +$138K ﹤0.01% 2514
2017
Q3 		$681K Sell
9,259
-424
-4% -$30.5K ﹤0.01% 2695
2017
Q2 		$701K Sell
9,683
-677
-7% -$44.6K ﹤0.01% 2710
2017
Q1 		$645K Sell
10,360
-287
-3% -$18.1K ﹤0.01% 2703
2016
Q4 		$775K Sell
10,647
-242
-2% -$15.7K ﹤0.01% 2666
2016
Q3 		$651 Hold
10,889
– – ﹤0.01% 2748
2016
Q2 		$686K Sell
10,889
-179
-2% -$11.5K ﹤0.01% 2717
2016
Q1 		$692K Sell
11,068
-1,385
-11% -$81.7K ﹤0.01% 2655
2015
Q4 		$729K Sell
12,453
-500
-4% -$28.4K ﹤0.01% 2760
2015
Q3 		$698K Hold
12,953
– – ﹤0.01% 2774
2015
Q2 		$772K Sell
12,953
-166
-1% -$9.34K ﹤0.01% 2822
2015
Q1 		$785K Sell
13,119
-531
-4% -$31.2K ﹤0.01% 2748
2014
Q4 		$820K Buy
13,650
+254
+2% +$14.1K ﹤0.01% 2765
2014
Q3 		$653K Sell
13,396
-1,181
-8% -$60K ﹤0.01% 2865
2014
Q2 		$750K Buy
14,577
+1,265
+10% +$64.9K ﹤0.01% 2883
2014
Q1 		$770K Hold
13,312
– – ﹤0.01% 2782
2013
Q4 		$761K Hold
13,312
– – ﹤0.01% 2814
2013
Q3 		$791K Sell
13,312
-409
-3% -$22.3K ﹤0.01% 2746
2013
Q2 		$745K Buy
+13,721
New +$646K ﹤0.01% 2766

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

TIAA CREF Investment Management's UTMD Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Utah Medical Products (UTMD) stake by 1.3% in Q1 2019, selling an estimated $8.09K and leaving 6,936 shares worth $612K. The position accounts for ﹤0.01% of the portfolio, ranked #2521.

TIAA CREF Investment Management first reported a position in UTMD in Q2 2013 and has held it in 24 quarters since. The position peaked at $897K in Q4 2017. 92 funds tracked by Wall St. Rank hold UTMD as of Q1 2019.

  • TIAA CREF Investment Management held 6,936 shares of Utah Medical Products worth $612K as of Q1 2019.
  • TIAA CREF Investment Management sold 92 Utah Medical Products shares in Q1 2019, an estimated $8.09K.
  • Utah Medical Products made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2521 holding.
  • TIAA CREF Investment Management first reported a position in Utah Medical Products in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Utah Medical Products position peaked at $897K in Q4 2017.
  • 92 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.